Wolverine Trading
MED icon

Wolverine Trading’s Medifast MED Stock Holding History

Wolverine Trading’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,900
Closed -$165K – 5258
2025
Q1 		$165K Buy
+11,900
New +$179K ﹤0.01% 4045
2024
Q4 		– Sell
-24,900
Closed -$479K – 5638
2024
Q3 		$479K Sell
24,900
-500
-2% -$9.63K ﹤0.01% 3098
2024
Q2 		$554K Buy
+25,400
New +$677K ﹤0.01% 2734
2023
Q4 		– Sell
-14,100
Closed -$1.06M – 4920
2023
Q3 		$1.06M Buy
+14,100
New +$1.25M ﹤0.01% 2075
2023
Q2 		– Sell
-8,200
Closed -$809K – 4653
2023
Q1 		$809K Buy
8,200
+6,100
+290% +$676K ﹤0.01% 2077
2022
Q4 		$242K Sell
2,100
-500
-19% -$58.2K ﹤0.01% 2968
2022
Q3 		$282K Buy
+2,600
New +$373K ﹤0.01% 3213
2022
Q2 		– Sell
-1,700
Closed -$291K – 5248
2022
Q1 		$291K Hold
1,700
– – ﹤0.01% 3928
2021
Q4 		$358K Sell
1,700
-300
-15% -$62K ﹤0.01% 3907
2021
Q3 		$397K Sell
2,000
-4,400
-69% -$1.08M ﹤0.01% 4284
2021
Q2 		$1.79M Buy
6,400
+3,600
+129% +$976K ﹤0.01% 2100
2021
Q1 		$598K Sell
2,800
-1,600
-36% -$383K ﹤0.01% 3465
2020
Q4 		$849K Buy
+4,400
New +$778K ﹤0.01% 2573
2019
Q3 		– Sell
-42,200
Closed -$5.41M – 4765
2019
Q2 		$5.41M Buy
42,200
+18,000
+74% +$2.5M 0.02% 838
2019
Q1 		$3.09M Sell
24,200
-6,000
-20% -$761K 0.01% 1188
2018
Q4 		$3.75M Sell
30,200
-12,600
-29% -$2.16M 0.01% 987
2018
Q3 		$9.48M Buy
42,800
+22,600
+112% +$4.58M 0.02% 585
2018
Q2 		$1.89M Hold
20,200
– – ﹤0.01% 1642
2018
Q1 		$1.89M Buy
20,200
+15,600
+339% +$1.17M ﹤0.01% 1642
2017
Q4 		$321K Buy
+4,600
New +$305K ﹤0.01% 3533

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wolverine Trading's MED Position: Q2 2025 in Review

Wolverine Trading sold out of Medifast (MED) in Q2 2025, closing a stake of 13,044 shares — an estimated $180K sold.

Wolverine Trading first reported a position in MED in Q4 2017 and held it in 13 quarters. The position peaked at $2.31M in Q2 2019. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

  • Wolverine Trading reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 13,044 Medifast shares in Q2 2025, an estimated $180K.
  • Wolverine Trading first reported a position in Medifast in Q4 2017 and held it in 13 quarters.
  • Wolverine Trading's Medifast position peaked at $2.31M in Q2 2019.
  • 120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.